Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on February 15, 2013. The filing serves as a Regulation FD disclosure regarding operational milestones for the Company's ClearPoint system as of December 31, 2012.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on operational unit counts rather than financial performance metrics.
Material Changes and Operational Data
The Company announced two key operational data points for the twelve months ended December 31, 2012:
- The total number of ClearPoint system installations as of December 31, 2012.
- The number of ClearPoint disposable units sold during the twelve months ended December 31, 2012.
Specific numerical values for these metrics are contained in the attached press release (Exhibit 99.1) and are not explicitly stated in the body of this 8-K filing.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no duty or obligation to publicly update or revise the information contained in this report. The data is intended to be considered in the context of other SEC filings and public announcements. No forward-looking guidance or specific risk factors are detailed in this specific filing text.
Investor Verification Checklist
- Verify the specific number of ClearPoint system installations and disposable units sold by reviewing Exhibit 99.1 (Press Release dated February 15, 2013).
- Confirm the registrant name is MRI Interventions, Inc., as the input metadata referenced "Clearpoint Neuro, Inc."
- Review subsequent SEC filings for any updates to the operational data provided in this report.